Obesity Experts Meet with Senior FDA Officials on the Need for Innovation
On March 22, representatives of four major groups concerned with obesity met with senior officials from the FDA to discuss the concerns about barriers to innovation in the treatment of obesity. Leaders from the Obesity Society, Obesity Action Coalition, American Society for Metabolic and Bariatric Surgery, and the American Dietetic Association met with Janet Woodcock, MD, and senior members of her staff. Woodcock is director of the FDA’s Center for Drug Evaluation and Research. FDA commented that such meetings are not common.
“We’re trying to move the dialogue forward,” said Louis Aronne, MD, after the meeting. Other leaders from the obesity expert community in the meeting included Donna Ryan, MD; Patrick O’Neill, PhD; Ted Kyle, RPh; Francesca Dea, CAE; Jeanne Blankenship, MS, RD; Joseph Nadglowski, Jr; Christopher Gallagher; and Georgeann Mallory, RD. For more information on this story, see…
